| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 273 | 282 | 111 | 15 | | Cost of Revenue | 247 | 286 | 172 | 43 | | | Gross Profit | 26 | (4) | (61) | (28) | | | Operating Expenses | | Research Development | 1,626 | 1,486 | 2,191 | 5,828 | | Selling General and Administrative | 1,952 | 2,764 | 2,807 | 1,052 | | Non Recurring |
-
|
-
|
-
| (87) | | Others | 479 | 443 | 424 | 367 | | | | Total Operating Expenses |
-
|
-
|
-
| 7,160 | | | | Operating Income or Loss | (4,163) | (4,696) | (5,483) | (7,188) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (139) | 5 | 11 | 31 | | Earnings Before Interest And Taxes | (4,170) | (4,691) | (5,473) | (7,157) | | Interest Expense | (78) | 76 | 67 | 71 | | Income Before Tax | (4,092) | (4,767) | (5,540) | (7,228) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,092) | (4,767) | (5,540) | (7,228) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,092) | (4,767) | (5,540) | (7,228) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,092) | ($4,767) | ($5,540) | ($7,228) |
|
0.27% Nasdaq 
Income Statement
